Endometrial stromal sarcoma – Diagnostics – Overview of Information and Clinical Research

Endometrial stromal sarcoma is a rare cancer that starts in the connective tissue of the uterus lining, with diagnosis often requiring several tests because its symptoms can look like common, noncancerous conditions. Getting the right diagnosis early matters, as it shapes your treatment plan and outlook.

Introduction: Who Should Seek Diagnostic Testing

If you notice unusual vaginal bleeding—especially bleeding that happens between periods, bleeding that is heavier than usual during your cycle, or any bleeding after you have gone through menopause—it’s important to talk with your doctor. While these symptoms are common and often point to noncancerous problems, they can sometimes signal endometrial stromal sarcoma or other uterine conditions that need attention.^[1]

Pain in your pelvic or stomach area that doesn’t go away, pain when you urinate, or a lump or mass you can feel in your lower belly are also reasons to see a healthcare provider. Some people with endometrial stromal sarcoma may also notice abnormal discharge from the vagina, constipation, or changes in how often they need to urinate.^[2]^[12]

Because symptoms of this cancer overlap with noncancerous conditions like fibroids (benign growths in the uterus), adenomyosis (a condition where the uterine lining grows into the uterine wall), and endometrial polyps (growths on the inner lining of the uterus), doctors can sometimes misdiagnose the condition at first. This is why persistent or worsening symptoms, even if you’ve been told they’re nothing to worry about, deserve a second look.^[1]

⚠️ Important

Some people with endometrial stromal sarcoma do not experience any symptoms at all, which means the cancer might only be discovered during tests or procedures done for other reasons. If you are in the age group most commonly affected—typically between 40 and 60 years old—staying current with routine gynecological checkups can help catch unusual changes early.^[2]

Women who have taken certain medications, such as tamoxifen for breast cancer treatment, or who have had radiation therapy to the pelvis in the past may be at slightly higher risk for developing uterine sarcomas. If you fall into these categories and develop new or unusual symptoms, it’s especially important to seek diagnostic testing.^[4]

The median age at diagnosis is around 55 years, and the condition affects people who have a uterus. It is extremely rare, with only about 79 cases diagnosed each year in England, for example. Despite this rarity, doctors need to consider the possibility of endometrial stromal sarcoma when someone presents with rapid enlargement of the uterus or fibroids that change quickly, as these can be warning signs.^[2]^[3]

Diagnostic Methods: How Doctors Identify Endometrial Stromal Sarcoma

Initial Evaluation and Physical Examination

The first step in diagnosing endometrial stromal sarcoma typically begins with your doctor asking about your symptoms and medical history. They will want to know details about your bleeding patterns, pain, and any other changes you’ve noticed. A physical examination, including a pelvic exam, allows the doctor to look for and feel any unusual lumps or masses in the pelvic or abdominal region.^[2]

Imaging Tests

Once your doctor suspects a problem, they will likely order imaging tests to get a clearer picture of what’s happening inside your body. These tests create images that help doctors see the size, location, and characteristics of any abnormal growths.

Transvaginal ultrasound is often one of the first imaging tests used. During this test, a healthcare provider gently inserts an ultrasound probe into the vagina. This probe uses sound waves to create detailed images of the uterus and surrounding structures. It’s a common, safe, and relatively quick procedure that can reveal masses or unusual tissue in the uterus.^[1]^[2]

Doctors may also use other imaging methods such as CT scans (computed tomography), MRI scans (magnetic resonance imaging), or PET scans (positron emission tomography). These scans take pictures of the inside of the body using different technologies—X-rays, magnets and radio waves, or radioactive tracers—and can show whether cancer has spread to other parts of the body like the pelvis, abdomen, or lungs.^[2]

Hysteroscopy

Hysteroscopy is a procedure where a doctor inserts a thin, lighted tube called a hysteroscope through the vagina and cervix into the uterus. This allows them to look directly at the inside of the uterus and see any unusual growths or changes. During this procedure, the doctor can also take a small tissue sample, called a biopsy, if needed.^[1]^[2]

Biopsy and Tissue Sampling

A biopsy is the most definitive way to diagnose endometrial stromal sarcoma. During a biopsy, a small piece of tissue is removed from the uterus or the suspected tumor and examined under a microscope by a specialist called a pathologist. The pathologist looks at the cells to determine whether they are cancerous and, if so, what type of cancer is present.^[2]

In some cases, an endometrial aspiration may be performed. This involves using a thin tube to gently suction out cells from the lining of the uterus. This sample is then tested in a laboratory. Endometrial aspiration can sometimes provide a diagnosis before surgery is needed.^[3]

However, it’s important to understand that in many cases, the final diagnosis of endometrial stromal sarcoma is confirmed only after surgery. This is because the condition is rare and can look like benign fibroids or other noncancerous growths before the tissue is examined closely. In one case report, a woman had rapid enlargement of a presumed fibroid, which led doctors to perform an endometrial aspiration before surgery. The aspiration showed low-grade endometrial stromal sarcoma, which was later confirmed when the uterus was removed and examined.^[3]

Distinguishing Endometrial Stromal Sarcoma from Other Conditions

Because symptoms of endometrial stromal sarcoma often mimic those of more common conditions, distinguishing this cancer from benign problems is a key challenge. Fibroids, for example, are very common noncancerous growths in the uterus. They can cause heavy bleeding and pelvic pain, just like endometrial stromal sarcoma. However, one red flag that might point toward sarcoma is rapid growth of the uterus or a fibroid, especially within a short period such as a few months.^[3]

Other conditions that can be confused with endometrial stromal sarcoma include adenomyosis and endometrial polyps. Doctors use a combination of imaging, clinical judgment, and ultimately tissue examination to make the correct diagnosis.^[1]

Grading the Cancer

Once endometrial stromal sarcoma is diagnosed, doctors will classify it as either low-grade or high-grade. This classification, called grading, helps predict how the cancer will behave. Low-grade endometrial stromal sarcoma means the cancer cells look somewhat similar to normal cells and tend to grow slowly. High-grade endometrial stromal sarcoma means the cancer cells look very different from normal cells and may grow and spread more quickly.^[1]^[2]

In a pathology report, low-grade ESS might describe worm-like stromal cell changes that may grow into the uterine muscle wall and pelvic lymph nodes. High-grade ESS describes more aggressive cell changes that have divided quickly and may have already spread outside the uterus by the time of diagnosis.^[1]

Staging the Cancer

After diagnosing endometrial stromal sarcoma, doctors will determine the stage of the cancer. Staging tells you how far the cancer has spread and helps guide treatment decisions. In general, staging works like this:

Stage I: Cancer is found only in the uterus.
Stage II: Cancer has spread within the pelvis beyond the uterus.
Stage III: Cancer has spread to areas in the abdomen outside the pelvis.
Stage IV: Cancer has spread to distant areas outside the abdomen, or to organs like the bladder or rectum.^[4]

Staging may involve additional imaging tests, such as chest X-rays or CT scans, to check whether cancer has spread to the lungs or other distant sites. In some cases, doctors may also check lymph nodes during surgery to see if cancer cells have traveled there.^[2]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or approaches to managing diseases. For people with endometrial stromal sarcoma, participating in a clinical trial may offer access to promising new therapies that are not yet widely available. However, to qualify for a clinical trial, patients must meet specific criteria, and diagnostic tests play a key role in determining eligibility.

Confirming the Diagnosis

The first requirement for most clinical trials is a confirmed diagnosis of endometrial stromal sarcoma. This usually means that a pathologist has examined tissue from a biopsy or surgery and identified the cancer. Trials may specify whether they are enrolling people with low-grade or high-grade endometrial stromal sarcoma, so the grade of your cancer matters.^[1]

Determining Disease Stage and Extent

Clinical trials often have strict criteria about the stage of cancer they are studying. Some trials may focus on early-stage disease (such as stage I or II), while others may be looking specifically at advanced or metastatic disease (cancer that has spread to other parts of the body). To determine your eligibility, doctors will use the same imaging and staging tests described earlier—ultrasound, CT, MRI, or PET scans—to see where the cancer is located and whether it has spread.^[2]

Assessing Overall Health

Beyond confirming the cancer diagnosis and stage, clinical trials typically require information about your overall health. This may include blood tests to check your kidney and liver function, heart tests like an electrocardiogram (ECG), and other evaluations to ensure you are healthy enough to participate in the trial. These tests help researchers understand whether the experimental treatment is safe for you.^[2]

Molecular and Genetic Testing

Some clinical trials for endometrial stromal sarcoma may require additional testing to look at the genetics or molecular features of the cancer. Scientists have discovered that certain genetic changes, such as a specific chromosomal change called translocation t(7;17), are common in endometrial stromal sarcoma. Trials that are testing treatments targeting these specific genetic changes may ask for tumor samples to be tested before you can enroll.^[6]

⚠️ Important

If you are interested in joining a clinical trial, talk to your healthcare team. They can help you understand what tests you need, what trials might be a good fit for your situation, and how to enroll. Keep in mind that clinical trials are research, not guaranteed treatment, and they come with both potential benefits and risks that should be carefully discussed with your doctor.

Monitoring Response to Treatment

Once enrolled in a clinical trial, you will likely undergo regular diagnostic tests to monitor how the cancer is responding to the experimental treatment. These might include repeat imaging scans, blood tests, and biopsies. Monitoring helps researchers understand whether the treatment is working and whether any adjustments need to be made.^[2]

Standard Criteria Across Trials

While specific criteria vary from trial to trial, common standard requirements include confirmation of cancer type and grade, accurate staging, and baseline health assessments. Researchers design these criteria to ensure that the people enrolled in the trial are the ones most likely to benefit from or provide useful information about the treatment being tested.

Prognosis and Survival Rate

Prognosis

The prognosis for people with endometrial stromal sarcoma depends primarily on how far the cancer has spread at the time of diagnosis. For those whose cancer is found early and confined to the uterus, the outlook is generally more favorable. Low-grade endometrial stromal sarcoma tends to grow slowly and has a better prognosis compared to high-grade disease, which is more aggressive and often diagnosed at a later stage.^[1]^[2]

Both low-grade and high-grade endometrial stromal sarcoma have a high rate of recurrence, meaning the cancer can come back even after successful treatment. Recurrences can happen many years after the initial diagnosis—sometimes even 20 years later. This is why long-term follow-up and monitoring are essential. Despite recurrences, many patients with endometrial stromal sarcoma can live for many years with appropriate treatment and management.^[1]^[6]^[20]

Factors that can affect prognosis include the grade of the cancer (low versus high), the stage at diagnosis, whether the cancer has spread to lymph nodes or distant organs, and how completely the cancer can be removed with surgery. Women with early-stage disease who undergo complete surgical removal of the cancer have the best chance of long-term survival and potential cure.^[6]

Survival Rate

Specific survival statistics for endometrial stromal sarcoma are difficult to generalize because the disease is so rare. However, research shows that people with low-grade endometrial stromal sarcoma often have a good long-term survival, even if the cancer recurs. In one study of patients with recurrent endometrial stromal sarcoma, many lived for years after their first relapse, with some experiencing multiple recurrences over time but continuing to respond to treatment.^[20]

High-grade endometrial stromal sarcoma has a less favorable prognosis. Because it grows and spreads more quickly, it is often diagnosed at a more advanced stage. Despite this, treatments including surgery, chemotherapy, and targeted therapies can help control the disease and extend survival. One patient with high-grade endometrial stromal sarcoma who received chemotherapy combined with targeted therapy was alive and continuing treatment 16 months after diagnosis, showing that even advanced disease can sometimes be managed for extended periods.^[9]

Overall, the prognosis for endometrial stromal sarcoma varies widely depending on individual circumstances. Early detection, complete surgical removal, and appropriate follow-up treatment all play critical roles in improving outcomes. Because the disease is rare, it is important to work with specialists who have experience treating uterine sarcomas to get the best care possible.

#1 Clinical Trials Search in Europe